Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model

Around 40% of high-risk prostate cancer patients who undergo radiotherapy (RT) will experience biochemical failure. Chemotherapy, such as docetaxel (DTX), can enhance the efficacy of RT. Multidrug resistance mechanisms often limit drug efficacy by decreasing intracellular concentrations of drugs in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Main Authors: Mirjolet, Céline, Boudon, Julien, Loiseau, Alexis, Chevrier, Sandy, Boidot, Romain, Oudot, Alexandra, Collin, Bertrand, Martin, Etienne, Joy, Pattayil Alias, Millot, Nadine, Créhange, Gilles
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587207/
https://ncbi.nlm.nih.gov/pubmed/28919739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S139167
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados